Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1977 Apr;11(4):656–660. doi: 10.1128/aac.11.4.656

Susceptibility of Clinical Isolates of Cytomegalovirus to Human Interferon

Bosko Postic *, John N Dowling 1
PMCID: PMC352045  PMID: 193440

Abstract

Human cell culture-derived interferon was shown to inhibit human cytomegalovirus in vitro. A prototype strain, Davis, and six clinical isolates of cytomegalovirus were tested. All six isolates showed uniform susceptibility to interferon, exceeding that of the Davis strain by two- to fourfold. The latter virus was found to be 32 to 4 times less susceptible than the sensitive indicator, vesicular stomatitis virus. However, the laboratory finding of susceptibility to an antiviral material may not relate to its clinical effectiveness.

Full text

PDF
656

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong J. A. Semi-micro, dye-binding assay for rabbit interferon. Appl Microbiol. 1971 Apr;21(4):723–725. doi: 10.1128/am.21.4.723-725.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Armstrong J. A., Tarr G. C., Youngblood L. A., Dowling J. N., Saslow A. R., Lucas J. P., Ho M. Cytomegalovirus infection in children undergoing open-heart surgery. Yale J Biol Med. 1976 Mar;49(1):83–91. [PMC free article] [PubMed] [Google Scholar]
  3. Arvin A. M., Yeager A. S., Merigan T. C. Effect of leukocyte interferon on urinary excretion of cytomegalovirus by infants. J Infect Dis. 1976 Jun;133 (Suppl):A205–A210. doi: 10.1093/infdis/133.supplement_2.a205. [DOI] [PubMed] [Google Scholar]
  4. Ch'ien L. T., Cannon N. J., Whitley R. J., Diethelm A. G., Dismukes W. E., Scott C. W., Buchanan R. A., Alford C. A., Jr Effect of adenine arabinoside on cytomegalovirus infections. J Infect Dis. 1974 Jul;130(1):32–39. doi: 10.1093/infdis/130.1.32. [DOI] [PubMed] [Google Scholar]
  5. Emödi G., O'Reilly R., Müller A., Everson L. K., Binswanger U., Just M. Effect of human exogenous leukocyte interferon in cytomegalovirus infections. J Infect Dis. 1976 Jun;133 (Suppl):A199–A204. doi: 10.1093/infdis/133.supplement_2.a199. [DOI] [PubMed] [Google Scholar]
  6. Fiala M., Chow A. W., Miyasaki K., Guze L. B. Susceptibility of herpesviruses to three nucleoside analogues and their combinations and enhancement of the antiviral effect of acid pH. J Infect Dis. 1974 Jan;129(1):82–85. doi: 10.1093/infdis/129.1.82. [DOI] [PubMed] [Google Scholar]
  7. Glasgow L. A., Hanshaw J. B., Merigan T. C., Petralli J. K. Interferon and cytomegalovirus in vivo and in vitro. Proc Soc Exp Biol Med. 1967 Jul;125(3):843–849. doi: 10.3181/00379727-125-32220. [DOI] [PubMed] [Google Scholar]
  8. Havell E. A., Vilcek J. Production of high-titered interferon in cultures of human diploid cells. Antimicrob Agents Chemother. 1972 Dec;2(6):476–484. doi: 10.1128/aac.2.6.476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ho M., Suwansirikul S., Dowling J. N., Youngblood L. A., Armstrong J. A. The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med. 1975 Nov 27;293(22):1109–1112. doi: 10.1056/NEJM197511272932201. [DOI] [PubMed] [Google Scholar]
  10. Ho M., Tan Y. H., Armstrong J. A. Accentuation of production of human interferon by metabolic inhibitors. Proc Soc Exp Biol Med. 1972 Jan;139(1):259–262. doi: 10.3181/00379727-139-36122. [DOI] [PubMed] [Google Scholar]
  11. Kraybill E. N., Sever J. L., Avery G. B., Movassaghi N. Experimental use of cytosine arabinoside in congenital cytomegalovirus infection. J Pediatr. 1972 Mar;80(3):485–487. doi: 10.1016/s0022-3476(72)80514-6. [DOI] [PubMed] [Google Scholar]
  12. McCracken G. H., Jr, Luby J. P. Cytosine arabinoside in the treatment of congenital cytomegalic inclusion disease. J Pediatr. 1972 Mar;80(3):488–493. doi: 10.1016/s0022-3476(72)80515-8. [DOI] [PubMed] [Google Scholar]
  13. Myers J. D., Spencer H. C., Jr, Watts J. C., Gregg M. B., Stewart J. A., Troupin R. H., Thomas E. D. Cytomegalovirus pneumonia after human marrow transplantation. Ann Intern Med. 1975 Feb;82(2):181–188. doi: 10.7326/0003-4819-82-2-181. [DOI] [PubMed] [Google Scholar]
  14. Postic B., Schleupner C. J., Armstrong J. A., Ho M. Two variants of Sindbis virus which differ in interferon induction and serum clearance. I. The phenomenon. J Infect Dis. 1969 Sep;120(3):339–347. doi: 10.1093/infdis/120.3.339. [DOI] [PubMed] [Google Scholar]
  15. Reynolds D. W., Stagno S., Stubbs K. G., Dahle A. J., Livingston M. M., Saxon S. S., Alford C. A. Inapparent congenital cytomegalovirus infection with elevated cord IgM levels. Casual relation with auditory and mental deficiency. N Engl J Med. 1974 Feb 7;290(6):291–296. doi: 10.1056/NEJM197402072900601. [DOI] [PubMed] [Google Scholar]
  16. Rytel M. W., Kauffman H. M. Clinical efficacy of adenine arabinoside in therapy of cytomegalovirus infections in renal allograft recipients. J Infect Dis. 1976 Feb;133(2):202–205. doi: 10.1093/infdis/133.2.202. [DOI] [PubMed] [Google Scholar]
  17. Spencer E. S. Clinical aspects of cytomegalovirus infection in kidney-graft recipients. Scand J Infect Dis. 1974;6(4):315–323. doi: 10.3109/inf.1974.6.issue-4.04. [DOI] [PubMed] [Google Scholar]
  18. Weller T. H. The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. I. N Engl J Med. 1971 Jul 22;285(4):203–214. doi: 10.1056/NEJM197107222850406. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES